Portfolio company
Undecimal Bio
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
This company develops targeted siRNA delivery molecules for pharmaceutical partners to treat renovascular diseases using an AI-enabled screening platform.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Serna Bio
This company develops an AI-native platform to discover small molecule drugs targeting RNA for pharmaceutical partners treating respiratory and other complex diseases.
Novarna
This company develops an artificial intelligence platform to design and validate RNA therapeutics for biopharmaceutical partners.
CircNova
This biotechnology company develops an artificial intelligence platform to design circular RNA therapeutics for biopharmaceutical partners to treat cancer and neurodegenerative diseases.
Animate Biosciences
This company develops AI-designed peptide therapeutics for patients with inflammatory and fibrotic diseases using multi-omic data from regenerative species.
UbiquiTx
This company develops a programmable protein modulation platform using artificial intelligence to create targeted therapies for pharmaceutical businesses and patients with complex diseases.
Kerna
This company develops an artificial intelligence platform to design and deliver messenger ribonucleic acid medicines for patients with previously untreatable conditions.
Noara Therapeutics
This company engineers stable and immunosilent ribonucleic acid therapies using machine intelligence to treat patients with chronic and complex diseases.
Creyon Bio
This company develops AI-designed oligonucleotide-based medicines and RNA-targeted therapies for pharmaceutical partners and patients with neuromuscular and immunological diseases.
